Graves' Disease News and Research

RSS
Graves’ disease, also known as toxic diffuse goiter, is the most common cause of hyperthyroidism in the United States. Hyperthyroidism is a disorder that occurs when the thyroid gland makes more thyroid hormone than the body needs.
ATA recognizes 4th Annual World Thyroid Day

ATA recognizes 4th Annual World Thyroid Day

Researchers discover molecular mechanisms behind autoimmunity

Researchers discover molecular mechanisms behind autoimmunity

Take charge of your medical tests

Take charge of your medical tests

Research may lead to new treatment strategies for Graves' disease

Research may lead to new treatment strategies for Graves' disease

Positive results from Lithera's LIPO-102 Phase IIb clinical study for abdominal fat reduction

Positive results from Lithera's LIPO-102 Phase IIb clinical study for abdominal fat reduction

Lithera receives Notice of Allowance from USPTO for LIPO-102 patent application

Lithera receives Notice of Allowance from USPTO for LIPO-102 patent application

Anthera initiates PEARL-SC Phase 2b study of A-623 for lupus

Anthera initiates PEARL-SC Phase 2b study of A-623 for lupus

UB study: Vietnam veterans exposed to Agent Orange are more likely to develop Graves' disease

UB study: Vietnam veterans exposed to Agent Orange are more likely to develop Graves' disease

ATA members raise concern about reduction in dietary iodine intake

ATA members raise concern about reduction in dietary iodine intake

Personalized treatments for thyroid disorders to be presented at ATA meeting

Personalized treatments for thyroid disorders to be presented at ATA meeting

Positive results from Phase IIa clinical study of LIPO-102

Positive results from Phase IIa clinical study of LIPO-102

AARDA launches campaign on family AQ

AARDA launches campaign on family AQ

Lithera announces positive results from Phase IIa clinical study of LIPO-102

Lithera announces positive results from Phase IIa clinical study of LIPO-102

March designated as 'National Autoimmune Diseases Awareness Month'

March designated as 'National Autoimmune Diseases Awareness Month'

Immune cells causes inflammation in thyroid-associated ophthalmopathy

Immune cells causes inflammation in thyroid-associated ophthalmopathy

Fibrocytes associated with Graves' disease

Fibrocytes associated with Graves' disease

Thyretain TSI Reporter BioAssay test for detecting auto-antibodies attains the FDA clearance

Thyretain TSI Reporter BioAssay test for detecting auto-antibodies attains the FDA clearance

Scientists gain new insights into the genetic susceptibility of multiple sclerosis

Scientists gain new insights into the genetic susceptibility of multiple sclerosis

Experts say propylthiouracil should not longer be used as first-line treatment for Graves' disease in children

Experts say propylthiouracil should not longer be used as first-line treatment for Graves' disease in children

Men get autoimmune diseases, too!

Men get autoimmune diseases, too!